Cell-Based Therapy for Silicosis
Joint Authors
Lopes-Pacheco, Miquéias
Bandeira, Elga
Morales, Marcelo M.
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2015), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-03-15
Country of Publication
Egypt
No. of Pages
9
Abstract EN
Silicosis is the most common pneumoconiosis globally, with higher prevalence and incidence in developing countries.
To date, there is no effective treatment to halt or reverse the disease progression caused by silica-induced lung injury.
Significant advances have to be made in order to reduce morbidity and mortality related to silicosis.
In this review, we have highlighted the main mechanisms of action that cause lung damage by silica particles and summarized the data concerning the therapeutic promise of cell-based therapy for silicosis.
American Psychological Association (APA)
Lopes-Pacheco, Miquéias& Bandeira, Elga& Morales, Marcelo M.. 2016. Cell-Based Therapy for Silicosis. Stem Cells International،Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1116691
Modern Language Association (MLA)
Lopes-Pacheco, Miquéias…[et al.]. Cell-Based Therapy for Silicosis. Stem Cells International Vol. 2016, no. 2016 (2015), pp.1-9.
https://search.emarefa.net/detail/BIM-1116691
American Medical Association (AMA)
Lopes-Pacheco, Miquéias& Bandeira, Elga& Morales, Marcelo M.. Cell-Based Therapy for Silicosis. Stem Cells International. 2016. Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1116691
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1116691